|
|
|
LINKS TO THE LEFT CONTAIN MORE INFORMATION What we do
|
|
Name |
Clinical Appointment |
Basic Science Appointment |
|
Byers |
Genetics |
Pathology |
|
Chait |
Metabolism, Endocrinology & Nutrition |
Pathology |
|
Clowes |
Surgery, Vascular Surgery |
Pathology |
|
Dichek |
Medicine, Cardiology |
Pathology |
|
Harlan |
Medicine, Hematology |
Pathology |
|
Horwitz |
Medicine, Medical Genetics |
Genome Sciences |
|
Jarvik |
Medicine, Medical Genetics |
Genome Sciences |
|
Lernmark |
Medicine, Endocrinology |
Immunology |
|
Schnapp |
Medicine, Pulmonary Medicine |
Pathology |
|
Schwartz |
Pathology, Cardiology |
Pathology, Bioengineering |
|
Murry |
Pathology |
Pathology, Bioengineering |
|
Liles |
Medicine, Infectious Disease |
Pathology |
Another way to illustrate our success in interdisciplinary research is our programmatic research career grants involving CVP faculty
|
PI |
CVP FACULTY |
|
|
Biology of the Artery Wall |
Harlan |
Giachelli, Chait, Clowes, Harlan, Raines, Wight |
|
Mechanisms of Acute Vascular Reaction to Injury (HL 03174) |
Schwartz |
Bowen-Pope, Harlan, Murry, Schwartz, Santana |
|
Bioengineering Research Partnership |
Ratner |
Bornstein, Hauschka, Murry, Ratner, Sage |
|
University of Washington Engineered Biomaterials (UWEB) Engineering Research Center (NSF EEC-9529161-05) |
Ratner |
Bornstein, Clowes, Giachelli, Hauschka, Murry, Ratner, Sage, Wight |
|
NHLBI Bioengineering Research Partnership |
Ratner |
Hauschka, Ratner, Bornstein, Murry |
|
Gene Therapy for Sickle Cell Disease (HL 53750) |
Stamatoyannopoulos |
Stamatoyannopoulos, Horwitz |
|
Molecular biology of hematopoietic stem cells: Project 3B Cellular and genetic basis for cyclic hematopoiesis (Horwitz) (NIH P01 DK55820) |
Stamatoyannopoulos |
Horwitz, Stamatoyannopoulos |
|
Molecular Analysis of Signal Transduction in the Heart (HL 44948) |
Catterall |
Catterall, Beavo, McKnight, Storm, Feigl, Klevit |
|
Atherosclerosis in Diabetes (DK 02456) |
Chait |
Chait, Deeb, Wight |
|
Lipoprotein Pathophysiology (5 PO1 HL 30086) |
Albers |
Albers, Chait, Jarvik |
|
UW-FHCRC Variation Discovery Resource (HL66682) “Seattle SNP Consortium” |
Nickerson |
The resource is used by Jarvik, Harlan, Schwartz, et al |
|
SCOR Acute Lung Injury (NIH P01 HL30542) |
Hudson, L. |
Harlan |
|
Immunogenetics of human diabetes (NIH PO1 DK53004) |
Lernmark |
Lernmark |
|
Genetic control of BB rat autoimmunity (NIH POl AI42380) |
Lernmark |
Lernmark |
|
Molecular and Genetic Mechanisms of Advanced Plaque Progression (Fondation Leducq - pending) |
Dichek |
Schwartz, Nickerson, Jarvik, Dichek, Bornfeldt, Chait |
|
Genomic and Genetic Approaches to Plaque Rupture(1 PO1 HL072262-01 - pending) |
Schwartz |
Rosenfeld, Nickerson, Schwartz, Jarvik, Clowes, Rossini, Ruzzo, Harlan |
|
NHLBI Proteomics Center (pending) |
Aebersold |
Schwartz, Harlan, Raines, Glomset, Catterall |
We recognize that success as an independent investigator requires numerous skills beyond those required to design, execute, and interpret experiments. These “survival skills” include writing manuscripts and grants, speaking, biomedical ethics, financial management, mastering of strategies for finding jobs in academia and industry, and learning to mentor trainees. All fellows receive experience in grant writing. For predoctoral fellows, all departments require submission of a grant application in the form of a proposed thesis project as part of the General Exam. For postdoctoral fellows, we notify all fellows of non-NIH grant opportunities including AHA grants and starter grants available from the University Royalty Research Foundation and specific University Centers. All fellows are asked to apply for such funding by the end of their second year of training.
Vascular Biology Breakfast Club: All of our laboratories participate in the Breakfast Club (PATH 552 Anatomic Pathology Course) once a week. All CVP fellows must participate in this series. Traditionally, there is a lot of questioning and interruptions are encouraged for fellows as well as any visiting speaker, is a lot of questioning; interruptions are encouraged. Though listed as a course, Breakfast Club is actually an informal meeting that features invited lecturers, as well as UW faculty, fellows and CVP trainees. Trainees are expected to present their research at Breakfast Club, which is held on Tuesday mornings during Fall, Winter and Spring quarters. Special lectures may also be held on other days of the week and during the Summer quarter. Check schedules at Breakfast Club. Administrative support is provided by the Murry Lab and is funded by the Reaction to Injury Grant and the CVP Training Grant.
Biomedical Research Integrity Lecture Series: All University of Washington School of Medicine trainees funded by NIH (both predoctoral and postdoctoral) are required to participate in the Biomedical Research Integrity Lecture Series, a series of seminars and discussion sessions on the ethics of biomedical research. The BRI Committee, composed of members of the Faculty Council for Research, directors of School of Medicine training programs, as well as postdoctoral and graduate student trainee representatives, recommends topics and formats for the lectures and discussions. Topics vary each year and have included: authorship, data ownership, conflict of interest, data handling, human subjects, scientific misconduct, mentoring, peer review, grantsmanship, genetic research, and use of animals in research. Over 300 graduate student and postdoctoral trainees participate in the series each year, representing over 35 departments and degree granting programs. Attendance is taken and reported to departments who monitor their trainees’ participation. Trainees are allowed to participate in several BRI Series over the course of their traineeship, granting them a reasonable degree of flexibility in meeting the attendance requirement. In addition, the BRI Series has a growing library of resources (video, texts, websites) that it makes available to departments and programs so that they may extend and tailor ethics discussion within their own programs. Dr. Albert Berger, Associate Dean for Research and Graduate Education, welcomes student suggestions for this series.
Other Resources: Some of the skills, such as grantsmanship and bioethics, are the subjects of formal lecture series. For example, the UW Research Funding Service sponsors a monthly seminar series entitled “Grants for Lunch”. This series covers grant writing skills and strategies for both public and private funding agencies, with an emphasis on NIH funding mechanisms. The Department of Medicine sponsors a weeklong, biennial “Fellows’ Course”. Topics include scientific writing and oral presentations, grant writing, and an introduction to research mechanisms. We also invite mentors to meet with students.
Steering Committee: We require that all fellows be supervised by both their individual mentor and the Steering Committee. The latter is most effectively done by the annual reports and by our requirement that fellows present in the Breakfast Club.
CVP has a clear policy that encourages fellows to report any ethical concerns to their mentor or, if that is an issue, then to any member of the steering committee. Our definition of ethics includes: intellectual property, fair pay, non-discrimination based on gender, race, religion, sexual orientation, authorship on papers
Travel expense will be reimbursed if the CVP trainee’s mentor states that the travel fits in one of the following categories:
1. The trainee will be giving a talk or presenting a poster;
2. The meeting or course will provide critical insight or skills for the trainee; or
3. The meeting will assist in job placement searches for the trainee.
CVP Trainees are not funded for general meetings, e.g. AHA or FASEB, unless one of the conditions above is met.
The CVP grant does not provide separate travel funds. It does, however, provide approximately $500 per fellow per year to cover individual trainee’s travel expenses. If required to travel, the trainee must submit a request stating the title of the meeting or symposium, the dates, the items requested (e.g. air fare, registration fees, cab fares, meals, etc.) and the amount, as well as attaching the necessary forms. The grant administration will decide if and how much support will be granted. Generally, support has been provided in the past to cover trips to meetings and courses which have been well-justified under the guidelines above. Priority is given to trips for presentation of work done under the training grant and to attendance of specifically relevant courses.
Depending upon cost of travel, reimbursement will cover airfare, meals and accommodations up to the maximum limit. Generally, however, mentors have used CVP funds to only cover shortfalls under other grants.
The CVP training grant may cover lab supplies, computers, office supplies, and books.
|
|
Graduate Students |
Students in CVP Labs |
Students Currently |
|
34 |
19 |
1 |
|
|
24 |
7 |
2 |
|
|
92 |
16 |
2 |
|
|
87 |
0 |
0 |
|
|
39 |
1 |
1 |
|
|
147 |
5 |
0 |
|
|
15 |
0 |
0 |
|
|
27 |
2 |
0 |
New departments added as of 2002 and not shown, include Biostatistics and Computer Science. Traditionally, the two departments with the largest role in our predoctoral program are Pharmacology and Pathology. As of this date, however, the distribution is changing. We currently have only one student in Pharmacology, and two in Pathology. Two students are in Bioengineering and we are adding a new student in Genome Sciences under Dr. Jarvik.
The addition of Biostatistics to CVP reflects our growing interest in quantitative biology. The University of Washington Department of Biostatistics’ predoctoral program already includes a specialty in cardiovascular biostatistics. The program includes course work in both applied and theoretical statistics and biostatistics, including courses in statistical theory, introductory biostatistics, advanced applied statistics and linear models, design of medical studies, categorical data, survival analysis, multivariate statistical methods, statistical computing, design of medical studies, evaluation of new drugs and biologics in humans, and biologic courses. First and second year theory and applied examinations, a cardiovascular biology project and a thesis are required as well. Many students gain experience on ongoing projects including collaborative randomized clinical trials and epidemiologic projects (such as the Cardiovascular Health Study).
Biostatistics already has close liaison with clinical cardiology via collaborations with the Division of Cardiology and the Cardiovascular Research Training Center in the School of Medicine. The tie with CVP will encourage students to consider applying their skills to molecular biology.
CVP faculty in Biostatistics are Drs. Rossini and Kronmal. Dr. Rossini is a new faculty member who has been working with Drs. Schwartz and Jarvik on the problem of developing statistical models to link SNP data, clinical data and expression array data. Dr Kronmal has been Co-Principle Investigator and Co-Director of the Coronary Artery Surgery Study (CASS) Coordinating Center and Principle Investigator and Director of the Cardiovascular Health Study (CHS) Coordinating Center. Dr. Kronmal is best known to CVP for his work as the coordinator of the Multi-Ethnic Study of Atherosclerosis (MESA). MESA is a 10-year observational study of the characteristics of subclinical cardiovascular disease in an ethnically diverse population-based sample of 6,500 men and women. From the CVP point of view, the MESA data set offers outstanding opportunities for collaborations between an epidemiologist and molecular biologists.
It is important to note that Dr. Kronmal’s training grant (Cardiovascular Biostatistics Training, NIH 5 T32 HL07183-26) already supports the cardiovascular path for Biostatistics students entering this program with an interest in epidemiology. We expect, however, to use CVP to support the thesis and research efforts only of students choosing to work on projects in molecular biology labs. CVP may also support collaborative programs for students from other departments who seek out mentors in Biostatistics for help with informatics.
The Department of Genome Sciences is a new addition to both CVP and to the School of Medicine. Genome Sciences began in September 2001 by the fusion of the Departments of Genetics and Molecular Biotechnology. The goal of Genome Sciences is to address leading edge questions in biology and medicine by developing and applying genetic, genomic and computational approaches that take advantage of genomic information now available for humans, model organisms and a host of other species. Our faculty study a broad range of topics, including the genetics of E. coli, yeast, C. elegans, Drosophila and mouse; human and medical genetics; mathematical, statistical and computer methods for analyzing genomes, and theoretical and evolutionary genetics; and genome-wide studies by such approaches as sequencing, transcriptional and translational analysis, polymorphism detection and identification of protein interactions. Our department includes both faculty with primary appointments in Genome Sciences, as well as adjuncts in other departments and Seattle institutions. Eight faculty are members of the National Academy of Sciences, including 2001 Nobel Prize winner Dr. Lee Hartwell, who conducted much of his groundbreaking work in the Department of Genetics. Graduate research in the Department leads to a PhD in either Genetics or Molecular Biotechnology and students in either PhD program can opt for a focus in Computational Molecular Biology. Our department has about 60 graduate students. CVP faculty includes Drs. Nickerson (a member of the Steering Committee), Dr. Aebersold, and Dr. Jarvik.